Chemoinformaics analysis of 3-METHYL-6-PROPAN-2-YLCYCLOHEX-2-EN-1-ONE
| Molecular Weight | 152.237 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 23 |
| Exact Molecular Weight | 152.12 | nRing | 1 |
| Solubility: LogS | -5.239 | nHRing | 0 |
| Solubility: LogP | 4.516 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 0 | BPOL | 16.9193 |
| QED | 0.805 |
| Synth | 3.18 |
| Natural Product Likeliness | 2.291 |
| NR-PPAR-gamma | 0.8 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.652 |
| MDCK | 0.0000128 |
| BBB | 0.248 |
| PPB | 0.980418 |
| VDSS | 0.582 |
| FU | 0.0141576 |
| CYP1A2-inh | 0.651 |
| CYP1A2-sub | 0.781 |
| CYP2c19-inh | 0.964 |
| CYP2c19-sub | 0.781 |
| CYP2c9-inh | 0.939 |
| CYP2c9-sub | 0.889 |
| CYP2d6-inh | 0.891 |
| CYP2d6-sub | 0.651 |
| CYP3a4-inh | 0.905 |
| CYP3a4-sub | 0.506 |
| CL | 3.207 |
| T12 | 0.087 |
| hERG | 0.108 |
| Ames | 0.101 |
| ROA | 0.913 |
| SkinSen | 0.21 |
| Carcinogencity | 0.867 |
| EI | 0.071 |
| Respiratory | 0.939 |
| NR-Aromatase | 0.794 |
| Antiviral | No |
| Prediction | 0.91333 |